“…10 In the June 2024 issue of Respirology, Qin et al report their analysis of smoking cessation efficacy in Chinese patients with chronic obstructive pulmonary disease (COPD) who were randomly treated with varenicline or bupropion for 12 weeks. 11 A total of 224 participants were stratified as slow (NMR <0.31; 55%) or normal (NMR ≥0.31; 45%) metabolisers and followed for 24 weeks from the commencement of therapy. The primary outcome was abstinence at 9-12 weeks, and the secondary outcome was abstinence at 24 weeks and several visits throughout the study.…”